| Issue |
Section |
Title |
File |
| Vol 24, No 3 (2013) |
Articles |
A GENETIC PREDICTOR OF IMMEDIATE HYPERSENSITIVITY REACTIONS CAUSED BY β-LACTAM ANTIBIOTICS |
|
| Vol 24, No 12 (2013) |
Articles |
β 2-ADRENOCEPTOR GENE POLYMORPHISM AND THE COURSE OF ASTHMA |
|
| Vol 26, No 7 (2015) |
Articles |
PERSONALIZED MEDICINE IN BRONCHIAL OBSTRUCTION SYNDROME |
|
| Vol 26, No 10 (2015) |
Articles |
THERAPEUTIC EQUIVALENCE, BIOEQUIVALENCE AND INTERCHANGEABILITY OF MEDICINAL PRODUCTS |
|
| Vol 26, No 12 (2015) |
Articles |
USE OF THIOCTIC ACID IN PATIENTS WITH DIABETES MELLITUS TYPE 2 |
|
| Vol 26, No 8 (2015) |
Articles |
WORLD EXPERIENCE IN THE ASSESSMENT OF THE INTERCHANGEABILITY OF PRODUCTS FOR MEDICAL USE |
|
| Vol 26, No 11 (2015) |
Articles |
A PROCEDURE FOR INCREASNG BLOOD OXYGEN TENSION IN PATIENTS WITH CHRONIC HEART FAILURE |
|
| Vol 27, No 3 (2016) |
Articles |
METABOLIC AGENTS IN THE TREATMENT OF ALCOHOLISM AND DIFFERENT CENTRAL NERVOUS SYSTEM DISEASES |
|
| Vol 27, No 4 (2016) |
Articles |
KOKARNIT: AN ANALGESIC POTENTIAL IN THE TREATMENT OF DIABETIC POLYNEUROPATHY |
|
| Vol 27, No 9 (2016) |
Articles |
ROLE OF CYTOCHROME P450 3A4 IN THE METABOLISM OF DRUGS USED TO TREAT CHRONIC HEART FAILURE |
|
| Vol 29, No 7 (2018) |
Articles |
The innovative drug Polyhemostat in the treatment of bleeding |
|
| Vol 29, No 2 (2018) |
Articles |
Optimization of personalized therapy in patients with chronic heart failure |
|
